| Primary |
| Drug Use For Unknown Indication |
16.3% |
| Product Used For Unknown Indication |
13.5% |
| Hypertension |
10.6% |
| Hypertonic Bladder |
7.1% |
| Urinary Incontinence |
6.4% |
| Urine Abnormality |
5.7% |
| Cystitis Interstitial |
5.0% |
| Incontinence |
5.0% |
| Cardiac Disorder |
4.3% |
| Bladder Disorder |
2.8% |
| Blood Pressure |
2.8% |
| Breakthrough Pain |
2.8% |
| Constipation |
2.8% |
| Asthma |
2.1% |
| Blood Cholesterol |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Contraception |
2.1% |
| Eye Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| General Physical Condition |
2.1% |
|
| Dental Caries |
9.1% |
| Drug Ineffective |
9.1% |
| Lung Disorder |
9.1% |
| Aphasia |
6.1% |
| Cardiac Failure |
6.1% |
| Death |
6.1% |
| Intervertebral Disc Protrusion |
6.1% |
| Open Angle Glaucoma |
6.1% |
| Product Quality Issue |
6.1% |
| Tremor |
6.1% |
| Acne |
3.0% |
| Arrhythmia |
3.0% |
| Bladder Neoplasm |
3.0% |
| Coeliac Disease |
3.0% |
| Faeces Discoloured |
3.0% |
| Femoral Neck Fracture |
3.0% |
| Growth Retardation |
3.0% |
| Intentional Drug Misuse |
3.0% |
| Lung Cancer Metastatic |
3.0% |
| Nausea |
3.0% |
|
| Secondary |
| Hypertension |
28.8% |
| Urine Abnormality |
17.3% |
| Drug Use For Unknown Indication |
10.1% |
| Incontinence |
9.4% |
| Hypertonic Bladder |
4.3% |
| Urinary Incontinence |
4.3% |
| Blood Pressure |
3.6% |
| Breakthrough Pain |
2.9% |
| Depression |
2.9% |
| Bladder Disorder |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Drug Therapy |
1.4% |
| Enuresis |
1.4% |
| Faecal Incontinence |
1.4% |
| Fluid Retention |
1.4% |
| Gastric Disorder |
1.4% |
| Gout |
1.4% |
| Muscle Relaxant Therapy |
1.4% |
| Nausea |
1.4% |
|
| Lung Disorder |
30.0% |
| Drug Ineffective |
10.0% |
| Hypertension |
6.7% |
| Intentional Drug Misuse |
6.7% |
| Nausea |
6.7% |
| Urinary Incontinence |
6.7% |
| Arthropathy |
3.3% |
| Faeces Discoloured |
3.3% |
| Neoplasm Malignant |
3.3% |
| Oesophageal Carcinoma |
3.3% |
| Pain |
3.3% |
| Pancreatic Carcinoma |
3.3% |
| Product Quality Issue |
3.3% |
| Somnolence |
3.3% |
| Vision Blurred |
3.3% |
| Weight Decreased |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
11.2% |
| Multiple Sclerosis |
6.5% |
| Depression |
6.0% |
| Hypertension |
5.5% |
| Pain |
5.2% |
| Osteoporosis |
4.3% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Migraine |
3.3% |
| Rheumatoid Arthritis |
2.7% |
| Urinary Incontinence |
2.6% |
| Insomnia |
2.0% |
| Bladder Disorder |
1.9% |
| Arthritis |
1.9% |
| Diabetes Mellitus |
1.8% |
| Restless Legs Syndrome |
1.7% |
| Asthma |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Nausea |
1.6% |
| Supplementation Therapy |
1.6% |
|
| Weight Decreased |
17.2% |
| Urinary Tract Infection |
9.6% |
| Vomiting |
8.1% |
| Weight Increased |
6.7% |
| Death |
5.3% |
| Pyrexia |
5.3% |
| Urinary Incontinence |
4.8% |
| Dyspnoea |
4.3% |
| Tremor |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Tooth Abscess |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Urosepsis |
3.3% |
| Weight Loss Poor |
3.3% |
| Wound Infection Staphylococcal |
3.3% |
| Cellulitis |
2.9% |
| Drug Ineffective |
2.9% |
| Oedema Peripheral |
2.9% |
| Pain In Extremity |
2.9% |
| Pathological Gambling |
2.9% |
|
